Successful Therapeutic Management of Trypanosomosis in a Dog-A Case Report
Abstract
Background: Trypanosomosis is one of the most important and deadliest diseases of canines. Usually within 3 to 4 weeks an infected dog dies in the acute form of the disease. The use of inappropriate doses of anti-trypanosomatid drugs in animals leads to the development of huge resistance in the organisms.
Methods: The present study communicates the successive therapeutic management of clinical trypanosomiasis with five doses of diminazine aceturate injection. One mongrel dog came with the clinical signs of persistent fever, tachycardia, severe dehydration, pale mucous membrane, corneal opacity, prolonged recumbency, and enlargement of superficial lymph nodes. A Giemsa-stained thin blood smear revealed the presence of Trypanosoma organisms. Haematobiochemical parameters revealed lowered total leucocyte count, haemoglobin, total platelet count, serum total protein, and blood glucose levels and elevated levels of alkaline phosphatase, serum creatinine, and blood urea nitrogen.
Results: We observed the animal responded after the third day of post-therapy, and the clinical and haematobiochemical improvement was recorded after twenty days of post-therapy. The corneal opacity completely subsides after 28 days consequently.
Conclusions: During our study we found that the proper significant dosing of diminazine aceturate can cure the Trypanosomosis in dogs.
